Introducing the FDA Transparency Blog

This is new as of the other day ...

Introducing the FDA Transparency Blog

I want to thank Peggy Hamburg and the team at FDA for their leadership and work to make the FDA open and transparent.

Our Administration is committed to eliminating the barriers between the American people and their government, and the Task Force is another big step in the right direction.

The FDA is responsible for protecting the food we eat and the medicine we use -- its work impacts every American, and ensuring the agency is open and accountable to the American people is critical.

Thank you for taking the time to visit the Task Force blog and learn more about this effort. We appreciate your thoughts and ideas and look forward to hearing from you.

Sincerely,

Secretary Kathleen Sebelius
U.S. Department of Health and Human Services


Background

Providing information to the public in a user-friendly and timely manner is critically important to the work of the agency and its credibility with the public. I have formed a Transparency Task Force, chaired by Principal Deputy Commissioner Dr. Joshua Sharfstein, to provide me with recommendations about how to make FDA and its processes more transparent to the public.

If you have a suggestion about how to improve transparency at the agency, I encourage you to let the Task Force know by submitting or responding to a comment in the blog provided below.

In addition to this blog you can also submit electronic comments to the federal register at www.regulations.gov, submit written comments to the Division of Dockets Management, or attend a public meeting on Wednesday, June 24, 2009 in downtown DC with some members of the Task Force. Additional details about how you can engage with the Task Force can be found here. The first blog post is to inform you of this process and our policy. Thereafter, we will be asking for you feedback on specific topics.

Thank you for your input and participation.

Margaret A. Hamburg, M.D.
Commissioner of Food and Drugs

Comment Policy

This is a moderated blog. We expect that participants will treat each other with respect. All comments will be reviewed before posting. We will not post comments that contain vulgar or profane language; personal attacks of any kind; or offensive terms that target specific ethnic, religious or racial groups. We will not post comments that are clearly off topic, spam, or that promote services or products. Comments that make unsupported accusations will also not be posted.

Reporters are asked to send questions to the FDA Media Office through their normal channels and to refrain from submitting questions here as comments. Reporter questions will not be posted.

We recognize that the Web is a 24/7 medium, and your comments are welcome at any time. However, given the need to manage federal resources, moderating and posting of comments will occur during regular business hours Monday through Friday. Comments submitted after hours or on weekends will be read and posted as early as possible the next business day.

For the benefit of robust discussion, we ask that comments remain on-topic.

To protect your own privacy and the privacy of others, please do not include phone numbers or email addresses in the body of your comment.

Thank you for taking the time to read this comment policy. We encourage your participation in our discussion and look forward to an active exchange of ideas.

Posted on June 02, 2009 at 04:00 PM

URL for this news releases:
http://fdatransparencyblog.fda.gov/2009/06/transparency-blog.html

The FDA's Transparency Blog address:
http://fdatransparencyblog.fda.gov